Hunter likes hard tech and deep tech businesses because they have real moats and multi-year advantages, are less crowded and less linear than hot AI rounds, and provide multiple entry points. He specifically favors energy, mining, rare earths refining, magnet production, defense, and aerospace areas where SpaceX may not be competitive.
Hunter likes hard tech and deep tech businesses because they have real moats and multi-year advantages, are less crowded and less linear than hot AI rounds, and provide multiple entry points. He specifically favors energy, mining, rare earths refining, magnet production, defense, and aerospace areas where SpaceX may not be competitive.
Hunter sees late-stage biotech crossover investing as attractive because crossover and public-market investors can become aggressive or almost predatory at late stages, get good value or put structured deals in place, and companies can go public earlier. He also notes that new pure-play biotech fund formation remains scarce, creating a differentiated opportunity.